ALK rearrangements occur in 3–8% of NSCLC cases, are generally mutually exclusive with EGFR or KRAS mutations and commonly found in adenocarcinomas of younger patients with light or no smoking history [12–14]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.